High-precision Vericheck ddPCR Empty-Full Capsid Kit advances gene therapies

The Vericheck ddPCR Empty-Full Capsid Kit from Bio-Rad combines measuring viral titer and capsid titer, providing a high-precision assessment of both protein and DNA in droplets

11 Oct 2024

Product news

Using Bio-Rad’s Droplet Digital™ PCR technology, the new Vericheck ddPCR™ Empty-Full Capsid Kit analyzes minimal amounts of either crude lysate or purified samples to deliver robust, reproducible data for reliable assessment of AAV vector quality.

Designed for use on Bio-Rad’s Droplet Digital PCR Systems, the Kit’s cost-effective and accessible solution enables optimization of AAV vector characterization processes to streamline gene therapy development and production while supporting compliance with regulatory guidelines.

Stephen Kulisch, Vice President of Marketing for Bio-Rad’s Digital Biology Group, said, “Our new Vericheck ddPCR Empty-Full Capsid Kit delivers unmatched precision and specificity, along with ease of use and high-throughput capabilities, to provide our customers with a comprehensive solution for AAV vector characterization and to help drive the advancement of safe and effective gene therapies.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Related products

Request Quote for All Products

Vericheck ddPCR Mycoplasma Detection Kit
Bio-Rad
The probe-based Vericheck ddPCR Mycoplasma detection Kit brings confidence in testing for mycoplasma contamination. The specificity and reproducibility of this kit allows for a precise measurement of 112 mycoplasma species using droplet digital PCR.
(0)
Vericheck ddPCR HEK293 Residual DNA Quantification Kit
Bio-Rad
The Vericheck ddPCR HEK293 Residual DNA Quantification Kit, with a novel ddPCR assay, has been designed to quantify residual HEK293 DNA in biotherapeutics with high specificity and reproducibility, without the need for reference curves.
(0)
Vericheck ddPCR Replication Competent Lentivirus Kit
Bio-Rad
Lentiviruses are commonly used as viral vectors in cell and gene therapy production, delivering and steadily integrating desired genes into the genome of the host cell. However, they may also present health hazards to humans due to integration-mediated transformation and the creation of a RCL that can infect nontarget cells. While the current regulatory guidelines recommend a cell culture–based method for RCL testing, it is cumbersome and takes 30–45 days from sample to results. Bio-Rad’s Vericheck ddPCR™ RCL Kit is fast, cost-effective, specific, and a fully validated solution for lentivirus testing. Features and benefits Fast turnaround time: Results in as little as 8 hours High sensitivity: LOD of 0.35 copies/µl Reproducible results: Low CV of <10% between lots, users, plates and instruments Automated data analysis: Simplified workflow with positive controls included in the kit to aid automated results Comprehensive ddPCR workflow: Supports and provides flexibility to run multiple samples per run
(0)
Vericheck ddPCR HEK293 Residual DNA Quantification Kit
Bio-Rad
The Vericheck ddPCR HEK293 Residual DNA Quantification Kit, with a novel ddPCR assay, has been designed to quantify residual HEK293 DNA in biotherapeutics with high specificity and reproducibility, without the need for reference curves.
(0)